These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical pharmacology of MAO inhibitors: safety and future. Yamada M; Yasuhara H Neurotoxicology; 2004 Jan; 25(1-2):215-21. PubMed ID: 14697896 [TBL] [Abstract][Full Text] [Related]
3. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues. Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740 [TBL] [Abstract][Full Text] [Related]
4. Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors. Behl T; Kaur D; Sehgal A; Singh S; Sharma N; Zengin G; Andronie-Cioara FL; Toma MM; Bungau S; Bumbu AG Molecules; 2021 Jun; 26(12):. PubMed ID: 34207264 [TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase-B inhibitors in the treatment of Alzheimer's disease. Thomas T Neurobiol Aging; 2000; 21(2):343-8. PubMed ID: 10867219 [TBL] [Abstract][Full Text] [Related]
6. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review. Manzoor S; Hoda N Eur J Med Chem; 2020 Nov; 206():112787. PubMed ID: 32942081 [TBL] [Abstract][Full Text] [Related]
7. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases. Youdim MB; Fridkin M; Zheng H J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846 [TBL] [Abstract][Full Text] [Related]
8. [Monoamine oxidase inhibitors: prospects for the use in clinical practice]. Evtushenko SK; Lutskiĭ IS; Efimenko VN; Kazarian NE Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(8):53-60. PubMed ID: 12233260 [No Abstract] [Full Text] [Related]
9. MAO-B inhibitors for the treatment of Parkinson's disease. Mov Disord; 2002; 17 Suppl 4():S38-44. PubMed ID: 12211138 [No Abstract] [Full Text] [Related]
10. Monoamine Oxidase-B (MAO-B) Inhibitors in the Treatment of Alzheimer's and Parkinson's Disease. Özdemir Z; Alagöz MA; Bahçecioğlu ÖF; Gök S Curr Med Chem; 2021; 28(29):6045-6065. PubMed ID: 33538661 [TBL] [Abstract][Full Text] [Related]
11. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease. Guay DR Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539 [TBL] [Abstract][Full Text] [Related]
12. [Monoamine oxidase as a target for drug action]. Drozak J; Kozłowski M Postepy Hig Med Dosw (Online); 2006; 60():498-515. PubMed ID: 17060892 [TBL] [Abstract][Full Text] [Related]
13. Monoamine oxidase inhibitors. A perspective on their use in the elderly. Volz HP; Gleiter CH Drugs Aging; 1998 Nov; 13(5):341-55. PubMed ID: 9829163 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging. Bar-Am O; Amit T; Kupershmidt L; Aluf Y; Mechlovich D; Kabha H; Danovitch L; Zurawski VR; Youdim MB; Weinreb O Neurobiol Aging; 2015 Mar; 36(3):1529-42. PubMed ID: 25499799 [TBL] [Abstract][Full Text] [Related]
16. [On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease]. Kassubek J; Büttner T; Reichmann H; Riederer P; Schulz JB; Wüllner U; Csoti I Fortschr Neurol Psychiatr; 2010 Mar; 78 Suppl 1():S34-6. PubMed ID: 20195940 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson's disease. Müller T; Riederer P; Grünblatt E J Neural Transm (Vienna); 2017 Jun; 124(6):745-748. PubMed ID: 28299453 [TBL] [Abstract][Full Text] [Related]
19. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors. Bainbridge JL; Page RL; Ruscin JM Neurol Clin; 2008 Aug; 26(3 Suppl):S85-96, vi. PubMed ID: 18774444 [TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase inhibitors and their pharmacological significance. Sandler M Acta Neurol Scand Suppl; 1983; 95():37-41. PubMed ID: 6428147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]